TNYA Stock Analysis: Buy, Sell, or Hold?
TNYA - Tenaya Therapeutics, Inc. Common Stock
$0.84
-0.09 (-10.14%)
▼
5d:
-15.99%
30d:
+12.45%
90d:
+27.3%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 06, 2026
0d
Smart Money Accumulation
TNYA is down 14.8% this week, but smart money is accumulating calls. Top strike: $1 2026-07-17 with 5,260 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When TNYA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
11 traders called TNYA this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TNYA is down 16.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: TNYA is down 16.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: TNYA is currently trading at $0.84, which is considered slightly high relative to its 30-day fair value range of $0.67 to $0.88. From a valuation perspective, the stock is trading at a discount (Forward PE: -2.2) compared to its historical average (10.3). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TNYA is in a strong uptrend. Immediate support is located at $0.72, while resistance sits at $1.15. Short-term momentum is weak, with the stock down 10.1% recently.
Market Sentiment: TNYA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.20 (+349.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TNYA is in a strong uptrend. Immediate support is located at $0.72, while resistance sits at $1.15. Short-term momentum is weak, with the stock down 10.1% recently.
Market Sentiment: TNYA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.20 (+349.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.67 -
$0.88
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
76.2%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-10.1%)
- BULLISH: Trading 349.2% below Wall St target ($4.20)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Recommendation downgraded due to -16.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.67 -
$0.88
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.72
Resistance Level
$1.15
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.25
Wall Street Target
$4.20
(+349.2%)
PE vs Historical
-2.3 vs 10.3
CHEAP
Share & Embed Analysis
Last updated: May 15, 2026 3:03 PM ET
Data refreshes hourly during market hours. Next update: 4:03 PM
Data refreshes hourly during market hours. Next update: 4:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNYA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Group Gp Lp Column III
SELL
3511826 shares
2026-02-25
Group Gp Lp Column III
SELL
658440 shares
2026-02-24
Faraz Ali
SELL
14862 shares
2026-02-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 55 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$23 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 55 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$208 | 52 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 60 BUY |
